Pregnancy and immunomodulatory therapy in multiple sclerosis patients
670
L.A. Hoffmann, T. Kumpfel, I. Heer, and R. Hohlfeld Pregnancy and immunomodulatory therapy in multiple sclerosis patients Nervenarzt 77 2006 663 668 670
The first case of mitoxantrone exposure in early pregnancy
DOI 10.1016/j.neuro.2006.10.002, PII S0161813X0600252X
M. De Santis, G. Straface, A.F. Cavaliere, P. Rosati, A.P. Badochi, and A. Caruso The first case of mitoxantron exposure in early pregnancy Neurotoxicology 28 2007 696 697 (Pubitemid 46843223)
Acute leukemia and pregnancy-fatal fetal outcome after exposure to idarubicin during the second trimester
E.E. Reynoso, and F. Huerta Acute leukemia and pregnancy-fatal fetal outcome after exposure to idarubicin during the second trimester Acta Oncol 33 1994 703 716
The Pierre Robin syndrome (glossoptosis, micrognathia, cleft palate). A review of 39 cases with emphasis on associated ocular lesions
J.L. Smith, and F.R. Stowe The Pierre Robin syndrome (glossoptosis, micrognathia, cleft palate). A review of 39 cases with emphasis on associated ocular lesions Pediatrics 27 1961 128 133
L.P. Jakobsen, M.A. Knudsen, J. Lespinase, C. Garcia Ayuso, C. Ramos, and J.P. Fryns The genetic basis of the Pierre Robin Sequence Cleft Palate Craniofac J 43 2 2006 155 159
Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosis
DOI 10.1212/01.wnl.0000168905.97207.d0
M. Sandberg-Wollheim, D. Frank, T.M. Goodwin, B. Giesser, M. Lopez-Bresnahan, M. Stam-Moraga, P. Chang, and G.S. Francis Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosis Neurology 27 2005 802 806 (Pubitemid 41362118)
AFFIRM Investigators. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
C.H. Polman, P.W. O'Connor, E. Havrdova, M. Hutchinson, L. Kappos, and D.H. Miller AFFIRM Investigators. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis N Engl J Med 354 2006 899 910